2015

Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells in Perianal Fistulas in CD

Post operative recurrence in CD active care or standard care

Intravenous golimumab induction therapy for ulcerative colitis

Early combo (antiTNF+antimetabolite) treatment vs conventional in CD

Therapeutic Targets in IBD

Infliximab dosage in IBD

Thalidomide in pediatric UC

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Randomised clinical trial: vercirnon, an oral CCR9 antagonist,vs. placebo as induction therapy in active Crohn’s disease

VSL3 in postoperative recurrence in CD